Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Gil

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Fetal Diagnosis and Therapy|November 7, 2013
First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testingK H Nicolaides, A Syngelaki, L C Poon, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 25, 2014
Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeksM S Quezada, M M Gil, C Francisco, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|June 4, 2016
ReplyM M Gil, R Revello, L C Poon, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|June 8, 2013
First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testingK H Nicolaides, D Wright, L C Poon, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|April 12, 2017
Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysisM M Gil, V Accurti, B Santacruz, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|February 3, 2015
Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysisM M Gil, M S Quezada, R Revello, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|May 21, 2020
Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic reviewJ Juan, M M Gil, Z Rong, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|October 11, 2014
UK NHS pilot study on cell-free DNA testing in screening for fetal trisomies: factors affecting uptakeM M Gil, G Giunta, E A Macalli, et al.
Fetal Diagnosis and Therapy|December 17, 2013
Assessment of fetal sex chromosome aneuploidy using directed cell-free DNA analysisKypros H Nicolaides, Thomas J Musci, Craig A Struble, et al.
Journal of Fish Biology|January 4, 2014
Adapting to the wild: the case of aquaculture-produced and released meagres Argyrosomus regiusM M Gil, M Palmer, A Grau, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Fetal Diagnosis and Therapy|November 7, 2013
First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testingK H Nicolaides, A Syngelaki, L C Poon, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 25, 2014
Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeksM S Quezada, M M Gil, C Francisco, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|June 4, 2016
ReplyM M Gil, R Revello, L C Poon, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|June 8, 2013
First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testingK H Nicolaides, D Wright, L C Poon, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|April 12, 2017
Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysisM M Gil, V Accurti, B Santacruz, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|February 3, 2015
Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysisM M Gil, M S Quezada, R Revello, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|May 21, 2020
Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic reviewJ Juan, M M Gil, Z Rong, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|October 11, 2014
UK NHS pilot study on cell-free DNA testing in screening for fetal trisomies: factors affecting uptakeM M Gil, G Giunta, E A Macalli, et al.
Fetal Diagnosis and Therapy|December 17, 2013
Assessment of fetal sex chromosome aneuploidy using directed cell-free DNA analysisKypros H Nicolaides, Thomas J Musci, Craig A Struble, et al.
Journal of Fish Biology|January 4, 2014
Adapting to the wild: the case of aquaculture-produced and released meagres Argyrosomus regiusM M Gil, M Palmer, A Grau, et al.
Pageof 5